Rakuten on February 29
Bloomage Biotechnology Co., Ltd. ***688363, **abbreviation: Bloomage Biotechnology) released a performance report yesterday. According to the report, Bloomage Biotech's revenue in 2023 will be 608.1 billion yuan, compared with 63.3 in the same period last year5.9 billion yuan, down 437%；
Bloomage Biotech will achieve a net profit attributable to owners of the parent company in 2023 of 58.7 billion yuan, compared with 9700 million yuan, down 395%；Deduct non-net profit 48.7 billion yuan, compared with 85.2 billion yuan, down 4285%。
Bloomage Biotech said that during the reporting period, the company continued to promote the "four-wheel drive" business layout, took the initiative to get rid of the path dependence on past success, and continued to promote the comprehensive upgrade and implementation of management reform. Management change is an inevitable action for the company to promote strategic upgrading and achieve long-term steady growth of the business, but it is affected by the differences in the competitive environment, development stage and development model of each business, which has different impacts on each business in the short term.
Among them, the raw material business still achieved steady growth, the medical terminal business maintained rapid growth, and the functional skin care products business showed a phased decline, and functional skin care products accounted for the largest proportion of the company's total operating income, so the total operating income decreased slightly compared with the same period last year.
Bloomage Biotech pointed out that the company will continue to focus on synthetic biology, adhere to the overall positioning of biotechnology companies and biomaterials companies, use scientific and technological strength to build product power, shape brand power, further increase cost reduction and efficiency increase, and promote the sustained, stable and healthy growth of the company's business.
Bloomage Biotech also announced that according to the company's management needs, the company's general manager proposed that Luan Yizheng continue to serve as the company's deputy general manager, in charge of investment management, and no longer serve as the chief financial officer;At the same time, it is proposed to appoint Wang Hui as the company's chief financial officer, responsible for the company's financial management.
Lei Di was founded by ** Lei Jianping, if ** please in**.